No man’s land: information needs and resources of men with metastatic castrate resistant prostate cancer
Author:
Funder
Sanofi (UK)
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s00520-016-3358-0.pdf
Reference17 articles.
1. de Bono JS, Oudard S, Ozguroglu M, et al. (2010) Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet 376:1147–1154
2. Berthold DR et al. (2008) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. JCO 26(2):242–245
3. Kantoff P, Higano CS (2012) Integration of immunotherapy into the management of advanced prostate cancer. Urol Oncol 30:S41–S47
4. de Bono JS, Logothetis CJ, Molina A, et al. (2011) Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364:1995–2005
5. Jenkins V, Fallowfield LJ, Poole K (2001) Are members of multidisciplinary teams in breast cancer aware of each other's informational roles? Quality in Health Care 10(2):70–75
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mobile Audio Recording Technology to Promote Informed Decision Making in Advanced Prostate Cancer;JCO Oncology Practice;2021-12-21
2. Strategies for living well with hormone-responsive advanced prostate cancer—a qualitative exploration;Supportive Care in Cancer;2020-07-06
3. Use and importance of different information sources among patients with rare diseases and their relatives over time: a qualitative study;BMC Public Health;2020-06-05
4. Patients’ and partners’ views of care and treatment provided for metastatic castrate‐resistant prostate cancer in the UK;European Journal of Cancer Care;2019-11
5. Experiences of Australian men diagnosed with advanced prostate cancer: a qualitative study;BMJ Open;2018-02-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3